Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction. 2002

Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, Saitama, Japan.

BACKGROUND Although plasma brain natriuretic peptide (BNP) levels have been widely measured in patients with acute myocardial infarction (AMI), it is still uncertain whether the early recanalization modulates the levels and whether the levels can predict chronic stage left ventricular function. This study was designed to elucidate these issues. METHODS In 80 consecutive patients with AMI, plasma BNP levels were measured at admission and at 4 hours, 24 hours, 48 hours, and 1 month after admission. RESULTS In 35 of the 80 patients, the infarct-related artery was patent within 6 hours from the onset of MI (6-hour patency group), and in 27 patients, the artery was still occluded after 6 hours (6-hour occlusion group). The remaining 18 patients in whom it was unclear whether recanalization of the infarct-related artery had occurred within 6 hours or not were excluded from the analyses. In the 6-hour patency group, the BNP level gradually increased and reached a maximum value at 24 hours after admission. In the 6-hour occlusion group, the level increased more, with the values at 4 hours, 24 hours, and 48 hours significantly higher than those in the 6-hour patency group (86 +/- 18 pmol/L versus 35 +/- 8 pmol/L; P <.01; 112 +/- 13 pmol/L versus 74 +/- 9 pmol/L; P <.05; 102 +/- 15 pmol/L versus 53 +/- 11 pmol/L; P <.01). Chronic stage left ventricular function was correlated with not only the BNP level at same stage but also that at 24 hours and that at 48 hours after admission. Multiple regression analysis indicated that the BNP level at 24 hours was the most powerful predictor of chronic stage left ventricular function. CONCLUSIONS Plasma BNP levels can predict subsequent cardiac function. In addition, the importance of early recanalization may also be supported with BNP kinetics.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014654 Vascular Patency The degree to which BLOOD VESSELS are not blocked or obstructed. Patency, Vascular,Patencies, Vascular,Vascular Patencies

Related Publications

Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
January 2011, Clinical Medicine Insights. Cardiology,
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
January 1997, Circulation,
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
June 1996, Circulation,
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
May 1993, Lancet (London, England),
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
December 2001, Heart (British Cardiac Society),
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
October 2001, The American journal of cardiology,
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
June 1996, Journal of the American College of Cardiology,
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
April 1998, International journal of cardiology,
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
May 1998, Circulation,
Teruo Inoue, and Masashi Sakuma, and Isao Yaguchi, and Keiichi Mizoguchi, and Toshihiko Uchida, and Kan Takayanagi, and Terumi Hayashi, and Shigenori Morooka
May 2008, Journal of the American College of Cardiology,
Copied contents to your clipboard!